Impact of body mass index on outcomes after robot assisted radical prostatectomy

Basit Öğe Kaydı
dc.contributor.authorCastle, Erik P.
dc.contributor.authorAtug, Fatih
dc.contributor.authorWoods, Michael
dc.contributor.authorThomas, Raju
dc.contributor.authorDavis, Rodney
dc.date.accessioned2024-04-24T16:00:07Z
dc.date.available2024-04-24T16:00:07Z
dc.date.issued2008
dc.departmentDicle Üniversitesien_US
dc.description.abstractIn this study we evaluated the impact of body mass index (BMI) on operative and perioperative parameters and surgical margin rates, in patients who underwent robotic assisted radical prostatectomy (RARP).We retrospectively reviewed 140 consecutive RARPs performed by the same surgical team. Patients were stratified based on BMI into two categories: Group I: non-obese (91 patients) and Group II: obese (49 patients). Intraoperative parameters evaluated were: total operative time, estimated blood loss (EBL), intraoperative complications, status of nerve sparing and pelvic lymph node dissection. Postoperative parameters evaluated included positive surgical margin rate, pathological Gleason score and pathological stage, final tumor volume, length of stay (LOS), and postoperative complications. The two groups were statistically comparable for age, PSA, Gleason scores and clinical stages. Mean operative time was greater in the obese group at 300.5 min versus 247.3 min in the non-obese group. Mean EBL in obese patients and non-obese patients were 396.2 and 292.8 ml, respectively. Positive surgical margin rate was 26.5% in obese and 13.1% in non-obese patients. Robotic assisted radical prostatectomy in obese patients is a feasible procedure with acceptable perioperative outcomes and complications. In our study, obesity significantly but negatively affected operative and postoperative outcomes. Moreover, obesity was associated with higher grade tumors and higher incidence of positive surgical margins. Consequently, caution is advised in performing RARP in the obese patient in the early part of a learning curve.en_US
dc.identifier.doi10.1007/s00345-007-0217-0
dc.identifier.endpage95en_US
dc.identifier.issn0724-4983
dc.identifier.issue1en_US
dc.identifier.pmid17940773
dc.identifier.scopus2-s2.0-39349112334
dc.identifier.scopusqualityQ1
dc.identifier.startpage91en_US
dc.identifier.urihttps://doi.org/10.1007/s00345-007-0217-0
dc.identifier.urihttps://hdl.handle.net/11468/14380
dc.identifier.volume26en_US
dc.identifier.wosWOS:000253130500014
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofWorld Journal of Urology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectRobotic Assisted Radical Prostatectomyen_US
dc.subjectBody Mass Indexen_US
dc.subjectLaparoscopyen_US
dc.subjectProstate Canceren_US
dc.titleImpact of body mass index on outcomes after robot assisted radical prostatectomyen_US
dc.titleImpact of body mass index on outcomes after robot assisted radical prostatectomy
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu